GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Daan Gene Co Ltd (SZSE:002030) » Definitions » Operating Margin %

Daan Gene Co (SZSE:002030) Operating Margin % : -39.85% (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Daan Gene Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Daan Gene Co's Operating Income for the three months ended in Mar. 2025 was ¥-67.4 Mil. Daan Gene Co's Revenue for the three months ended in Mar. 2025 was ¥169.1 Mil. Therefore, Daan Gene Co's Operating Margin % for the quarter that ended in Mar. 2025 was -39.85%.

The historical rank and industry rank for Daan Gene Co's Operating Margin % or its related term are showing as below:

SZSE:002030' s Operating Margin % Range Over the Past 10 Years
Min: -34.48   Med: 9.74   Max: 56.63
Current: -34.48


SZSE:002030's Operating Margin % is ranked better than
61.02% of 980 companies
in the Biotechnology industry
Industry Median: -115.345 vs SZSE:002030: -34.48

Daan Gene Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Daan Gene Co's Operating Income for the three months ended in Mar. 2025 was ¥-67.4 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-284.0 Mil.


Daan Gene Co Operating Margin % Historical Data

The historical data trend for Daan Gene Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daan Gene Co Operating Margin % Chart

Daan Gene Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.42 53.58 56.63 4.82 -26.88

Daan Gene Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.39 -24.82 -29.94 -41.76 -39.85

Competitive Comparison of Daan Gene Co's Operating Margin %

For the Biotechnology subindustry, Daan Gene Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daan Gene Co's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Daan Gene Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Daan Gene Co's Operating Margin % falls into.


;
;

Daan Gene Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Daan Gene Co's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=-229.316 / 853.024
=-26.88 %

Daan Gene Co's Operating Margin % for the quarter that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=-67.396 / 169.137
=-39.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daan Gene Co  (SZSE:002030) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Daan Gene Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of Daan Gene Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Daan Gene Co Business Description

Traded in Other Exchanges
N/A
Address
No.19 Xiangshan Road, Science Park, High & New Technology Development District, Guangdong, Guangzhou, CHN, 510665
Daan Gene Co Ltd is a high-tech enterprise-oriented in molecular diagnostic techniques. It is primarily committed to research and development, production, and service of in-vitro diagnostic products, including qPCR, Sequeacing, TRF, ELISA, and Liquid-Based Cytology diagnostic kits and equipment. Geographically, tahe group operates in China.
Executives
Zhou Xin Yu Directors, executives
He Yun Shao Director
Huang Ru Hui Supervisors
Cheng Gang Directors, executives
Xu Qing Supervisors
He Li Xin Supervisors

Daan Gene Co Headlines

No Headlines